VCM
ABUS icon

Voleon Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Voleon Capital Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.8K Buy
+19,741
New +$86.7K ﹤0.01% 749
2026
Q1 		– Sell
-16,387
Closed -$78.8K – 781
2025
Q4 		$78.8K Buy
16,387
+5,984
+58% +$26.9K ﹤0.01% 758
2025
Q3 		$47.2K Buy
+10,403
New +$38.2K ﹤0.01% 873

Other funds holding ABUS

TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WCM
Whitefort Capital Management New York $406M AUM 84.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Voleon Capital Management's ABUS Position: Q2 2026 in Review

Voleon Capital Management opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 19,741 shares worth $94.8K. The stake represents ﹤0.01% of the portfolio and ranks #749 among its holdings. This is a return to the name: Voleon Capital Management previously reported a position in ABUS as recently as Q4 2025.

Voleon Capital Management first reported a position in ABUS in Q3 2025 and has held it in 3 quarters since. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.

  • Voleon Capital Management held 19,741 shares of Arbutus Biopharma worth $94.8K as of Q2 2026.
  • Arbutus Biopharma was a new Voleon Capital Management position in Q2 2026.
  • Arbutus Biopharma made up ﹤0.01% of Voleon Capital Management's portfolio in Q2 2026, its #749 holding.
  • Voleon Capital Management first reported a position in Arbutus Biopharma in Q3 2025 and has held it in 3 quarters since.
  • 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.